Pharmacy News

Bristol-Myers Squibb Recalls Coumadin Injection

Cheryl A. Thompson

BETHESDA, MD 02 Jul 2014— Bristol-Myers Squibb Company External Link on Monday announced a recall of six lots of Coumadin for injection because visible particulate matter had been found in a small number of unreleased samples of the warfarin sodium product.

The six lots are 00201125, 00201126, 00201127, 00201128, 00201129, and 00201130.

Anyone with vials from these lots is being told not to use them and to call Genco, at 855-838-5784, to arrange for their return. Genco's regular business hours are 7 a.m. to 5 p.m. CST.

Bristol-Myers Squibb said it discontinued Coumadin for injection in early April 2014.

According to a company spokesman, the injectable product accounted for 0.02% of the total use of Coumadin in the United States.


Contact Us
For questions, comments, or more information on this article, please contact the ASHP News Center at
ASHP Product Listing